Related Experiment Video
Updated: Apr 12, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
25.6K
OnabotulinumtoxinA in overactive bladder: Evidence-based consensus recommendations
M A Jiménez-Cidre1, S Arlandis-Guzmán2,
1Servicio de Urología del Hospital Ramón y Cajal Madrid, España.
Actas Urologicas Espanolas
|May 27, 2015
Summary
This study provides recommendations for using onabotulinumtoxinA to treat overactive bladders (OAB). It details patient selection, administration, and follow-up for effective OAB management.
Area of Science:
- Urology
- Pharmacology
Background:
- Overactive bladder (OAB) syndrome significantly impacts quality of life.
- Current treatments for OAB may fail or be poorly tolerated.
Purpose of the Study:
- To provide practical recommendations for urologists initiating onabotulinumtoxinA treatment for OAB.
- To establish guidelines for safe and effective use of onabotulinumtoxinA in OAB management.
Main Methods:
- Literature search up to December 2013.
- Critical review of selected publications.
- Expert consensus from the Spanish Group for the use of Botulinum Toxin in Urology.
Main Results:
- OnabotulinumtoxinA is indicated for neurogenic or idiopathic detrusor overactivity causing urge incontinence when conservative/medical treatments fail.
- Treatment involves intravesical, epidural, or general anesthesia; patient counseling on catheterization is crucial.
- Antibiotic prophylaxis is recommended; follow-up includes visits at 7-14 days and 2-3 months, with retreatment as needed.
Conclusions:
- These guidelines aid clinicians in decision-making for onabotulinumtoxinA therapy.
- Adherence to recommendations can minimize risks associated with improper drug use.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.4K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
923
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
923
01:23Urinary Bladder
4.5K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.5K
01:21Drugs for Treatment of Constipation-Predominant IBS
1.3K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.3K
01:30Urinary Tract Calculi III: Medical Management
350
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
350
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K